-
NBA Grizzlies deal Morant to Portland: report
-
World Bank drops climate finance targets in renewed action plan
-
Sweden ready for 'game of our lives' in France World Cup clash
-
Ancelotti says never doubted 'suffering' Brazil would score
-
MLS Chicago Fire announce signing of Poland's Lewandowski
-
Venezuela's quake-hit La Guaira port 'operational': US military
-
Tech rebound lifts Dow to record, yen hits 40-year low against dollar
-
US Supreme Court rules on dragnet searches of cellphone location data
-
Madueke says he can be England's World Cup game-changer
-
South Korea fans target coach Hong with boos as World Cup squad returns
-
Switzerland returns famed Benin Bronzes to Nigeria
-
Vaughan calls for England change after Stokes bows out with defeat
-
Last-gasp Brazil down Japan to reach World Cup 16
-
Europe's deadly heatwave scorches east, Slovakia hits record
-
Spain confident despite World Cup injury setbacks, says Llorente
-
French Open champ Andreeva sails into Wimbledon second round
-
Martinelli scores in 95th minute to send Brazil into World Cup last 16
-
Shooter in custody dispute kills six at German family shelter
-
US races to reopen Venezuela port as quake deaths top 1,700
-
Latham hails 'old school' New Zealand after downing England
-
Serena set for much-anticipated Wimbledon return
-
US races to reopen Venezuela port for aid after twin quakes
-
Ex-NBA stars Malik Beasley, Ed Davis indicted in betting case
-
Paris funeral homes overwhelmed after record heatwave
-
France wary of Sweden side with 'nothing to lose' at World Cup
-
Pyjamas and bets: Brazil YouTube channel reshapes World Cup viewing
-
Bloodied but unbowed: Sinner avoids shock exit at start of Wimbledon title defence
-
Queueing, strawberries and all white: it must be Wimbledon
-
Top US court upholds $5mn Trump sex assault judgment
-
Stokes backs Brook '100 percent' to succeed him as England Test captain
-
Sinner survives scare to reach Wimbledon second round
-
Ebola outbreak in DR Congo spreads to fourth province
-
Six killed in German 'family tragedy' shooting: police
-
Czech Republic coach Koubek quits after World Cup flop
-
Osaka makes spectacular Wimbledon arrival in kimono-inspired dress
-
French parliament adopts bill to regulate fast fashion
-
Bolivia removes 15-year dollar peg in bid to revive economy
-
Supreme Court boosts Trump's power to fire officials, but protects Fed
-
Russia jails veteran who threatened Putin with mutiny
-
Three things we learned from the Austrian F1 Grand Prix
-
Five shot dead at German youth welfare site, two suspects arrested
-
Burnham pledges radical devolution of UK govt if PM
-
Polish businesses press Warsaw, Kyiv to end political rift
-
Tour de France 'ready to adapt' amid extreme heatwave
-
Hovland beats Scheffler in playoff for PGA Travelers title
-
New Zealand thrash England for series win as Stokes bows out
-
Man City hire Maresca to start new era after Guardiola
-
Trump says Iran meeting to take place in Qatar
-
Pegula slams Vondrousova's 'harsh' doping ban
-
Spain raises 2026 growth forecast despite Mideast war turmoil
The suffering of those who cannot feel pain
Patrice Abela first knew something was wrong when his eldest daughter was learning to walk and her feet left trails of blood behind her, yet she showed no sign of distress.
She was soon diagnosed with congenital insensitivity to pain, an extremely rare and dangerous genetic disorder that dooms sufferers to a lifetime of hurting themselves in ways they cannot feel.
Abela, a 55-year-old software developer in the southern French city of Toulouse, then watched in horror as his youngest daughter was revealed to have the same condition.
Now aged 12 and 13, the two girls spend around three months of every year in hospital.
"When they take a shower, they perceive hot and cold, but if it burns they don't feel anything," the father of four told AFP.
"Due to repeated infections, my eldest daughter lost the first joint of each of her fingers. She also had to have a toe amputated."
Repeated knee injuries have left both girls only able to move around using crutches or a wheelchair.
Abela said they may not feel physical pain but lamented their intense "psychological pain".
Aiming to raise awareness about the disease and "challenge the scientific community", Abela plans to run the equivalent of 90 marathons in fewer than four months. He plans to start on April 12, following the route of this year's Tour de France from Copenhagen to Paris.
- Danger everywhere -
A life without pain might sound like a dream come true but the reality is more like a nightmare.
There are only a few thousand known cases of the condition worldwide. The low number is believed to be partly due to sufferers often not living into adulthood.
"Pain plays a major physiological role in protecting us from the dangers of our environment," said Didier Bouhassira, a doctor at the centre for pain evaluation and treatment at Ambroise-Pare hospital in Paris.
In the most extreme cases, babies will "mutilate their tongue or fingers while teething", he told AFP.
Then comes "a lot of accidents, burns, walking on fractured limbs which heal badly", he added.
"They have to be taught what is innate in others: to protect themselves."
But when there are no warning signs, danger lurks everywhere.
Appendicitis, which announces itself in others via symptoms like pain and fever, can fester into a devastating general infection of the abdomen.
"Blindness can also occur because the eye must always be kept moist and the nervous system controls these processes via the so-called blink reflex," said Ingo Kurth of Germany's Institute of Human Genetics.
- New painkiller hopes -
Congenital insensitivity to pain (CIP) was first recognised in the 1930s, and numerous studies have since identified a genetic mutation that blocks a person's ability feel pain.
"We have learned that there are now more than 20 genetic causes of congenital or progressive insensitivity to pain," Kurth told AFP.
There is no cure and "no real drug breakthroughs have been made so far", Kurth said.
"But our understanding of the molecular causes of CIP continues to reveal new targets, and based on this, hopefully new therapies will be developed in the coming years."
There are also hopes that studying how CIP works could lead to the development of a new kind of painkiller, prompting huge interest from pharmaceutical giants seeking a fresh product in the billion-dollar industry of pain relief.
In this way, the unlucky few with CIP could contribute to the creation of a treatment that would help everyone in the world -- except themselves.
P.Stevenson--AMWN